What Is the Potential for Lumacaftor as a Chemical Chaperone in Promoting hERG Trafficking?
Zequn Zheng1,2, Yongfei Song2,3, Jiangfang Lian2,3
1Department of Cardiovascular, Medical College, Ningbo University, Ningbo, China.
Frontiers in Cardiovascular Medicine
|March 14, 2022
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Export of Misfolded Proteins out of the ER
4.0K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.0K
Carrier-Mediated Transport
575
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
575


